If you are wondering whether Illumina shares around US$120.09 still offer value or if the opportunity has passed, you are in the right place for a clear look at what the current price might imply. The ...

Genomics company Illumina (NASDAQ:ILMN) will be reporting results this Thursday after market close. Here’s what you need to know.

Illumina (ILMN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives a ...

In the preceding three months, 12 analysts have released ratings for Illumina ILMN, presenting a wide array of perspectives from bullish to bearish. The following table provides a quick overview of ...

Genetic sequencing company Illumina (ILMN) has had a rough few years. It has battled activist investors, faced off with the Federal Trade Commission, and, most recently, agreed to a $9.8 million ...

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year ...

Shares of Illumina Inc. ILMN slid 2.46% to $116.38 Wednesday, on what proved to be an all-around mixed trading session for ...

Illumina (ILMN) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.14 per share a year ago. These figures are ...

Illumina Inc. closed 22.79% short of its 52-week high of $155.53, which the company reached on January 22nd.

Wall Street expects a year-over-year increase in earnings on lower revenues when Illumina (ILMN) reports results for the quarter ended September 2025. While this widely-known consensus outlook is ...